Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study.
Saved in:
| Title: | Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study. |
|---|---|
| Authors: | Bishnoi, Sarwan1,2 (AUTHOR) sbishnoi@adelaidecancercentre.com.au, Kotasek, Dusan1,2 (AUTHOR), Aghmesheh, Morteza3 (AUTHOR), Yau, Thomas4 (AUTHOR), Cosman, Rasha5 (AUTHOR), Prawira, Amy5 (AUTHOR), Moore, Maggie6 (AUTHOR), Chan, Stephen L.7 (AUTHOR), Mant, Andrew8 (AUTHOR), Eek, Richard9 (AUTHOR), Zielinski, Robert10 (AUTHOR), Su, Rila11 (AUTHOR), Pan, Zhaoxuan11 (AUTHOR), Ma, Yiding12 (AUTHOR), Li, Fei12 (AUTHOR), Li, Peiqi12 (AUTHOR), Tse, Archie N.11 (AUTHOR) |
| Source: | Cancer (0008543X). Jun2024, Vol. 130 Issue 11, p1991-2002. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 177320612 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Bishnoi%2C+Sarwan%22">Bishnoi, Sarwan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> sbishnoi@adelaidecancercentre.com.au</i><br /><searchLink fieldCode="AR" term="%22Kotasek%2C+Dusan%22">Kotasek, Dusan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aghmesheh%2C+Morteza%22">Aghmesheh, Morteza</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yau%2C+Thomas%22">Yau, Thomas</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cosman%2C+Rasha%22">Cosman, Rasha</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Prawira%2C+Amy%22">Prawira, Amy</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moore%2C+Maggie%22">Moore, Maggie</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chan%2C+Stephen+L%2E%22">Chan, Stephen L.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mant%2C+Andrew%22">Mant, Andrew</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eek%2C+Richard%22">Eek, Richard</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zielinski%2C+Robert%22">Zielinski, Robert</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Su%2C+Rila%22">Su, Rila</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pan%2C+Zhaoxuan%22">Pan, Zhaoxuan</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ma%2C+Yiding%22">Ma, Yiding</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Fei%22">Li, Fei</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Peiqi%22">Li, Peiqi</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tse%2C+Archie+N%2E%22">Tse, Archie N.</searchLink><relatesTo>11</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+%280008543X%29%22">Cancer (0008543X)</searchLink>. Jun2024, Vol. 130 Issue 11, p1991-2002. 12p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=177320612 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cncr.35226 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 1991 Titles: – TitleFull: Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bishnoi, Sarwan – PersonEntity: Name: NameFull: Kotasek, Dusan – PersonEntity: Name: NameFull: Aghmesheh, Morteza – PersonEntity: Name: NameFull: Yau, Thomas – PersonEntity: Name: NameFull: Cosman, Rasha – PersonEntity: Name: NameFull: Prawira, Amy – PersonEntity: Name: NameFull: Moore, Maggie – PersonEntity: Name: NameFull: Chan, Stephen L. – PersonEntity: Name: NameFull: Mant, Andrew – PersonEntity: Name: NameFull: Eek, Richard – PersonEntity: Name: NameFull: Zielinski, Robert – PersonEntity: Name: NameFull: Su, Rila – PersonEntity: Name: NameFull: Pan, Zhaoxuan – PersonEntity: Name: NameFull: Ma, Yiding – PersonEntity: Name: NameFull: Li, Fei – PersonEntity: Name: NameFull: Li, Peiqi – PersonEntity: Name: NameFull: Tse, Archie N. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 0008543X Numbering: – Type: volume Value: 130 – Type: issue Value: 11 Titles: – TitleFull: Cancer (0008543X) Type: main |
| ResultId | 1 |